These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 10352211)
1. Interferon therapy: a double-edged sword? Cattran DC Am J Kidney Dis; 1999 Jun; 33(6):1174-6. PubMed ID: 10352211 [No Abstract] [Full Text] [Related]
2. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Reddy KR; Hoofnagle JH; Tong MJ; Lee WM; Pockros P; Heathcote EJ; Albert D; Joh T Hepatology; 1999 Sep; 30(3):787-93. PubMed ID: 10462387 [TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease. Van Thiel DH; Friedlander L; De Maria N; Molloy PJ; Kania RJ; Colantoni A Hepatogastroenterology; 1998; 45(20):328-30. PubMed ID: 9638401 [TBL] [Abstract][Full Text] [Related]
4. [What is the value of interferon therapy in chronic hepatitis?]. Böker KH; Manns MP Internist (Berl); 1997 Dec; 38(12):1191-203. PubMed ID: 9465324 [No Abstract] [Full Text] [Related]
5. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA. Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145 [TBL] [Abstract][Full Text] [Related]
6. Use of interferon for the treatment of chronic hepatitis C in the elderly. Eyigun CP; Van Thiel DH; De Maria N Hepatogastroenterology; 1998; 45(20):325-7. PubMed ID: 9638400 [TBL] [Abstract][Full Text] [Related]
7. Effector genes of interferon action against hepatitis C virus. Gale M Hepatology; 2003 May; 37(5):975-8. PubMed ID: 12717377 [No Abstract] [Full Text] [Related]
8. [Predictive value of diverse viral factors in the response to treatment with interferon in patients with chronic hepatitis C]. Giménez-Barcons M; Tajahuerce A; Sáiz JC Gastroenterol Hepatol; 1998 Oct; 21(8):404-12. PubMed ID: 9844281 [No Abstract] [Full Text] [Related]
10. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection. Sidhu-Malik NK; Kaplan AL J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of TT virus coinfection in patients with chronic hepatitis C treated with interferon. Brandhagen DJ; Gross JB; Zein NN Am J Gastroenterol; 1999 Jun; 94(6):1715-6. PubMed ID: 10364064 [No Abstract] [Full Text] [Related]
12. [Coinfection by human immunodeficiency virus and hepatitis C virus]. Lana Soto R; Mendoza Hernández JL; Lérida Urteaga AI; Alvarez-Sala Walther JL Rev Clin Esp; 1998 Apr; 198(4):237-41. PubMed ID: 9633210 [No Abstract] [Full Text] [Related]
13. [Chronic hepatitis C: new perspectives in therapy]. Zeuzem S Z Gastroenterol; 2004 May; 42(5):363-4. PubMed ID: 15136934 [No Abstract] [Full Text] [Related]
14. [Autoimmune hemolytic anemia caused by interferon?]. Hinrichsen H; Schmidt WE Dtsch Med Wochenschr; 1999 Mar; 124(11):339-40. PubMed ID: 10209537 [No Abstract] [Full Text] [Related]
15. Current treatment for chronic hepatitis C. Davis GL Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176 [TBL] [Abstract][Full Text] [Related]
16. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin. Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon. Guyader D; Boucher E; André P; Even C; Cottereau J; Bianchi A; Gasser P; Mendler MH; Deugnier Y; Brissot P Am J Gastroenterol; 1999 Jun; 94(6):1696-8. PubMed ID: 10364051 [TBL] [Abstract][Full Text] [Related]
18. [Endocrinal dysfunctions in liver failure of different etiologies and during interferon therapy in patients with chronic hepatitis B and C]. Lapiński TW; Dabrowska MM Pol Merkur Lekarski; 2008 May; 24(143):468-71. PubMed ID: 18634398 [TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients. Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137 [TBL] [Abstract][Full Text] [Related]
20. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]